Novara, Italy

Pier Luigi Canonico

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Alfasigma S.p.a.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pier Luigi Canonico. Retrieved from https://idiyas.com/inventor/pier-luigi-canonico

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pier Luigi Canonico: Innovator in Neurogenesis

Introduction

Pier Luigi Canonico is a notable inventor based in Novara, Italy. He has made significant contributions to the field of neurogenesis, particularly in developing compounds that can aid in the prevention of central nervous system disorders.

Latest Patents

Canonico holds a patent for "Compounds useful for increasing neurogenesis in neural tissue." This invention focuses on the use of acetyl L-carnitine, propionyl L-carnitine, or their salts for preparing a medicament aimed at enhancing neurogenesis. This increased neurogenesis is particularly beneficial for preventing disorders related to aging or genetic predisposition.

Career Highlights

Throughout his career, Canonico has worked with prominent organizations, including Alfasigma S.p.a. and Università Degli Studi Del Piemonte Orientale "Amedeo Avogadro." His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Canonico has collaborated with esteemed colleagues such as Mariagrazia Grilli and Aleardo Koverech. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Pier Luigi Canonico's work in neurogenesis represents a significant advancement in medical science, showcasing the potential of innovative compounds in addressing central nervous system disorders. His contributions continue to inspire further research in this vital area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…